Neuroprotective effects of E-PodoFavalin-15999 (Atremorine®)

CNS Neurosci Ther. 2017 May;23(5):450-452. doi: 10.1111/cns.12693. Epub 2017 Mar 30.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Brain Ischemia / drug therapy
  • Brain Ischemia / metabolism
  • Brain Ischemia / pathology
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Cell Survival / physiology
  • Dose-Response Relationship, Drug
  • Drug Evaluation, Preclinical
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • Hippocampus / pathology
  • Humans
  • Inflammation / drug therapy
  • Inflammation / metabolism
  • Inflammation / pathology
  • Lipopolysaccharides
  • Mice
  • Microglia / drug effects
  • Microglia / metabolism
  • Microglia / pathology
  • Neuroprotective Agents / pharmacology*
  • Oligomycins
  • Oxidative Stress / drug effects
  • Oxidative Stress / physiology
  • Oxidopamine
  • Parkinsonian Disorders / drug therapy
  • Parkinsonian Disorders / metabolism
  • Parkinsonian Disorders / pathology
  • Plant Preparations / pharmacology*
  • Rats
  • Rotenone
  • Tissue Culture Techniques

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Lipopolysaccharides
  • Neuroprotective Agents
  • Oligomycins
  • Plant Preparations
  • Rotenone
  • oligomycin A
  • Oxidopamine